ACLS Flashcards
(36 cards)
types of rhythms in cardiac arrest
pulseless electrical activity (PEA), asystole, ventricle fibrillation (VF), pulseless ventricular tachycardia (pVT)
non-shockable rhythms
asystole and PEA
shockable rhythms
pVT and VF
PEA and asystole treatment
- EPInephrine ASAP
- CPR 2 min cycles
epi every 3-5 min (every pulse check)
pVT and VF treatment
- shock
- cpr 2 min cycle
epi every 3-5 min (every pulse check)
repeat
routes of admin pearl
Intraosseous (IO) equivalent to IV
endotracheal tube (ETT) medications
NAVEL
-Naloxone
-Atropine
-Vasopressin
-Epinephrine
-Lidocaine
NAVEL dosing
2-2.5x IV dose, repeat the dose when IV access is secured
vasoactive agents goal
-increase BP and CO
-induce vasoconstriction and increase systemic vascular resistance, mean arterial pressure (MAP), and organ blood flow
vasoactive agents
epinephrine and vasopressin (but removed from ACLS guidelines)
epinephrine indications
VF, pVT, PEA, asystole
epinephrine dosing and formulation
formulation: 1mg/10mL syringes
dosing: 1mg IVP/IO q3-5min
(high dose not shown improvement over standard dose)
epinephrine after ROSC achieved and bradyarrythmias
start drip at 2-10 mcg/min
epinephrine side effects
tachycardia, hypertension, tissue necrosis if extravasation
anti arrhythmic agents
amiodarone, lidocaine, magnesium (torsades only)
antiarrythmic use
VF or pVT unresponsive to defibrillation
amiodarone formulation and dosing
formulation: 150mg/3mL vials
dosing: 300mg IV bolus
redose: 150mg IV bolus
amiodarone after ROSC achieved
bolus: 150mg IV over 10min followed by 20mL NS flush
maintenance: 1mg/min for 6 hrs, then 0.5mg/min over 18hrs
amiodarone side effects
hypotension and bradycardia
lidocaine formulations and dosing
formulation: 2% 100mg/5mL syringe
dosing: 1-1.5mg/kg IV/IO
redose: 0.5-0.75 mg/kg q5-10min
stable VT: 0.5-0.75 mg/kg IV
lidocaine after ROSC achieved
continuous infusion of 1-4 mg/min
lidocaine side effects
hypotension, bradycardia, heart block
magnesium (torsades) formulation and dosing
formulation: 50% 1g/2mL vial
dosing: 1-2g bolus flushed with 10-20mL NS
reversible causes of cardiac arrest (H&T): H’s
hypovolemia, hypoxia, hydrogen ions, hyperkalemia, hypothermia